Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice. [electronic resource]
Producer: 20151224Description: e0123122 p. digitalISSN:- 1932-6203
- Animals
- Catechin -- administration & dosage
- Cell Membrane -- drug effects
- Cytokines -- biosynthesis
- Fatty Acid Synthase, Type I -- biosynthesis
- Fatty Acids -- metabolism
- Gene Expression Regulation -- drug effects
- Hyperalgesia -- drug therapy
- Male
- Mice
- Neuralgia -- drug therapy
- Pain -- drug therapy
- Pain Threshold
- Peripheral Nerve Injuries
- Spinal Cord Injuries -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.